viernes, 1 de marzo de 2024

Clinical Trials Update from NCI, February 2024

https://content.govdelivery.com/accounts/USNIHNCI/bulletins/38dd2c2?reqfrom=share Repotrectinib Expands Treatment Options for Lung Cancers with ROS1 Fusions https://www.cancer.gov/news-events/cancer-currents-blog/2024/repotrectinib-lung-cancer-ros1?cid=eb_govdel NIH launches research network to evaluate emerging cancer screening technologies https://www.cancer.gov/news-events/press-releases/2024/cancer-screening-research-network-launches?cid=eb_govdel

No hay comentarios:

Publicar un comentario